Yes, they advise only (as per your ref above) and will not offer an opinion.
That makes the sentence "Tissue Therapies representatives will be seeking an opinion from SAWP that satisfactory results in these trials will provide sufficient safety and usefulness data to support approval of VitroGro." from the the company announcement (Page 7, The EMA's SAWP Procedure) wishful thinking.
Congratulations to hvalfisken, vango, et al. - you guys have been dead right about the missing trials. Sorry to all die-hard's, we are back to square two.
